Clinical trial
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or…
NCT00003345 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003345 |
|---|---|
| Title | Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer |
| Official title | Phase II Trial of Cisplatin and Irinotecan in Patients With Suboptimally Debulked, Incompletely Responding Ovarian Cancer |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, irinotecan hydrochloride |
| Enrollment | 35 |
| Start date | Oct 1, 1997 |
| Primary completion | Oct 1, 2001 |
| Completion | Oct 1, 2001 |
| First posted | Mar 30, 2004 |
| Last update posted | Jun 21, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: